Followers | 43 |
Posts | 8527 |
Boards Moderated | 3 |
Alias Born | 11/23/2003 |
Thursday, May 25, 2017 2:29:44 PM
…The Cosmetic giant..L’Oreal was very, very interested in Protokinetix’s molecule..AAGP to use in their
Cosmetic Empire…. Protokinetix and L’Oreal had an agreement but as the story go…But L’Oreal wanted total control over the molecule..AAGP and the agreement went South and the companies parted ways..
http://www.cosmeticsdesign.com/Formulation-Science/ProtoKinetix-claims-breakthrough-in-anti-aging-research
As the story goes…L’Oreal must have liked what they saw.. I found these two articles on the research that L’Oreal
had funded two different companies to help develop their own type of “Our”(PKTX)Anti-inflammatory molecule.
http://www.cosmeticsdesign.com/Formulation-Science/Ground-breaking-anti-aging-discovery-from-Antarctic-fish-gets-L-Oreal-excited
http://www.cosmeticsdesign-europe.com/Formulation-Science/Industry-falls-in-behind-L-Oreal-s-investment-in-breakthrough-discovery-from-Antarctic-fish
…AFGPs have proven useful in many applications. However, they are limited by their cost (approximately $10,000/gram), instability, and size (2,600 - 24,000 Daltons). Their large size restricts their use in medicine as they are unable to pass through capillaries into interstitial tissue and are unable to reach target cells. Molecules must be less than 600 Daltons to diffuse through the capillaries. In addition, molecules must be less than 1000 Daltons to pass through cell junctions into neighbouring cells and less than 600 Daltons to cross the blood-brain barrier.
.....With these issues in mind Dr. Geraldine-Castelot-Deliencourt invented AAGP ™ to be a smaller, more stable synthetic version of AFGP.
***With that Question in mind…"WHY..PKTX’s Molecule…AAGP"..
..The Answer is(IMHO).. Because….It Works… :+O
....ProtoKinetix Patents:
USA
Patent Number: US 8,394,362B2
Granted: March 12, 2013
Expires: March 12, 2033
Recent PKTX News
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/17/2024 07:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 07:13:41 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 05/15/2024 09:14:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 12:46:59 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM